ArticleFrontiers in oncology2023

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.